Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

DiaMedica Therapeutics Inc. (DMAC)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-20Dec-31-19Dec-31-18Dec-31-17
   10-K10-K10-K10-K
Revenues  0.00.00.50.0
            Revenue growth   -100.0%  
Cost of goods sold  0.00.00.00.0
Gross profit  0.00.00.50.0
            Gross margin    100.0% 
Selling, general and administrative   [+]4.43.72.71.3
Research and development  8.37.94.53.2
EBITDA   [+]-12.7-11.6-6.7-4.5
            EBITDA margin    -1349.2% 
Depreciation and amortization  0.00.00.00.0
EBIT   [+]-12.7-11.6-6.8-4.5
            EBIT margin    -1352.2% 
Other income (expense), net   [+]0.41.01.10.3
Pre-tax income  -12.3-10.6-5.7-4.3
Income taxes  0.00.00.10.0
            Tax rate     0.0%
Net income  -12.3-10.6-5.7-4.3
            Net margin    -1146.8% 
   
Basic EPS   [+]($0.78)($0.89)($0.74)($0.72)
Diluted EPS   [+]($0.78)($0.89)($0.74)($0.72)
   
Shares outstanding (basic)   [+]15.712.07.75.9
Shares outstanding (diluted)   [+]15.712.07.75.9
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy